NCT06404931View on ClinicalTrials.gov

Transvaginal Human Acellular Dermal Matrix for Prolapse Treatment

PHASE2RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2026

Conditions
Prolapse; FemaleProlapse GenitalProlapse Uterovaginal
Interventions
PROCEDURE

Vaginal hysterectomy plus matrix reinforcement and sacrospinous fixation with Anchorsure® device

Vaginal hysterectomy plus matrix reinforcement and sacrospinous fixation with Anchorsure® device

PROCEDURE

Vaginal hysterectomy plus anterior colporrhaphy

Vaginal hysterectomy plus anterior colporrhaphy

PROCEDURE

Vaginal hysterectomy plus sacrospinous fixation with Anchorsure® device

Vaginal hysterectomy plus sacrospinous fixation with Anchorsure® device

Trial Locations (1)

08221

RECRUITING

Hospital Mutua de Terrassa, Terrassa

All Listed Sponsors
collaborator

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

collaborator

Germans Trias i Pujol Hospital

OTHER

collaborator

Hospital Arnau de Vilanova

OTHER

lead

Hospital Mutua de Terrassa

OTHER